
Welltower (WELL) Stock Forecast & Price Target
Welltower (WELL) Analyst Ratings
Bulls say
Welltower is poised for continued success in the healthcare REIT market, with a strong portfolio of diversified properties and a strategic focus on countries with mature healthcare systems. With a data-driven approach and efficient operating partnerships, the company should continue to outperform the industry and drive strong growth. Our expectations for elevated AFFO growth over the next 6 years support our $230/share price target and Outperform rating.
Bears say
Welltower is a healthcare REIT with a diverse portfolio of properties, but its recent roll-out of the WBS system has been dilutive and may impact the company's ability to drive growth. Plus, a tightening capital markets environment and potentially more modest SHOP growth could lead to reduced investor confidence and a lower valuation for the stock. There is also potential for risks in terms of elevated investment volume and potential misses in underwriting. Overall, there are concerns about the sustainability of Welltower's current growth trajectory and potential for downside in the near future.
This aggregate rating is based on analysts' research of Welltower and is not a guaranteed prediction by Public.com or investment advice.
Welltower (WELL) Analyst Forecast & Price Prediction
Start investing in Welltower (WELL)
Order type
Buy in
Order amount
Est. shares
0 shares